TENANTS

Archive | Featured

JangoBio

Researchers with JangoBio, a Madison-based startup developing stem cell therapies, are set to begin testing on companion animals such as dogs within the next two months.

Bill Kohl, chief operating officer for JangoBio, says this marks a step forward in the company’s journey to bring its anti-aging therapy to market, starting with non-agricultural animals. “Things look promising,” Kohl told WisBusiness.com. “We’re working on refining the application, increasing and improving efficacy, and of course monitoring for safety.” JangoBio’s patent-pending therapy relies on […]

Continue Reading
Flugen

Study shows promising results for flu vaccine, Madison’s FluGen says

An experimental flu vaccine developed by a Madison company reduced flu virus levels and symptoms in people exposed to a mismatched strain, according to study results released Tuesday. The study by FluGen Inc., founded by UW-Madison scientists Yoshi Kawaoka and Gabriele Neumann, simulated the mismatch that frequently occurs when flu strains circulating in winter don’t […]

Continue Reading
UW-Renewable

Study: transition to renewable energy could create 162,000 jobs in Wisconsin

Moving away from fossil fuels could create thousands of jobs, improve public health, and increase overall economic activity by nearly $14 billion in Wisconsin, according to a new study. Despite providing the frac sand used to extract oil and natural gas, Wisconsin has no significant fossil fuel deposits to exploit and generates three-quarters of its […]

Continue Reading
Thomas “Rock” Mackie

UW Health: Mackie brings expansive entrepreneurial talent to lead new innovation initiative

UW Health has selected Thomas “Rock” Mackie to be the inaugural leader of the health system’s innovation initiative, which it is pursuing in partnership with the UW School of Medicine and Public Health. Mackie, who was also named chief innovation officer at UW Health, is a well-known member of Madison’s biotechnology sector as a researcher, […]

Continue Reading
invenra

Invenra and WARF Initiate a Collaboration to Discover and Develop Novel Therapeutics to Fight Neuroblastoma in Children

Invenra and WARF (Wisconsin Alumni Research Foundation) today announced they have entered into a collaboration to discover and develop a bispecific antibody therapeutic for the treatment of neuroblastoma, a cancer that is the third most common childhood cancer, after leukemia and brain tumors. The collaboration will use Invenra’s proprietary SNIPERTM technology to allow for precise […]

Continue Reading
Warf_logo_CMYK

Researchers invent new method to create hybrid yeast strains

UW-Madison researchers have developed a new method for creating hybrid yeast strains for use in commercial fermentation and brewing. An info sheet from the Wisconsin Alumni Research Foundation shows interspecies yeast hybrids are needed to produce certain fermented beverages. For example, the globally popular lager beer is made with hybrids of Saccharomyces cerevisiae and Saccharomyces […]

Continue Reading
excat-sciences

Exact Sciences to report $454-455M in total revenue, 71-percent growth for 2018

– Cologuard test volume increased 64 percent, with approximately 934,000 tests completed in 2018 – Nearly 15,000 health care providers ordered their first Cologuard test during the fourth quarter – We expect approximately 94 percent of patients who completed a Cologuard test during the fourth quarter to have no out-of-pocket costs READ FULL STORY  

Continue Reading